George de Urioste
Board Member; Director of HeartBeam Inc, Inc. (NASDAQ: BEAT)
George is a distinguished leader in the finance and business community in Silicon Valley and the broader United States, with over 35 years of experience. He has held pivotal roles such as COO, CFO, and CEO at renowned organizations, including Pluribus Networks, Marvell Technology, Chordiant Software, Remedy Corporation, and Aeroprise, Inc. He has navigated an impressive track record of IPOs, substantial M&A deals, and capital-raising ventures, amounting to over $½ billion.
Starting his career as a CPA in the big-four accounting industry followed by subsequent executive roles, George possesses extensive board experience, notably as Chair of the Audit Committees at Bridgelux, Inc., Vendavo, Inc., Saba Software, Inc., GCT Semi, Inc., Rainmaker Systems, Inc., and Montalvo Arts Center. George was also appointed a member of President George Bush’s National Information Technology Advisory Committee. Currently, he serves as a Director of HeartBeam, Inc., a publicly traded medical device company, where he chairs the Audit Committee and is a member of the Compensation Committee.
George’s career highlights include his tenure as CFO for Remedy Corporation, which was recognized as the “#1 Hot Growth Company” in America by Business Week. He has spoken at Forbes magazine’s annual CFO conference, authored multiple articles, and been featured in The Wall Street Journal’s “CFO Journal.” He has delivered guest lectures at prestigious institutions like the University of California at Berkeley, Cambridge University in the UK, and Baylor University.
George holds a Master of Business Administration from the University of California at Berkeley and a Bachelor of Science in Accounting/Business from the University of Southern California.
